Company profile for Rubedo Life Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Rubedo Life Sciences is an anti-aging company based in the Silicon Valley, California. Rubedo mission is to extend health-span by targeting cell in the body in an accurate and safe way. We aim to remove from the body "bad cells"​ that drive agin (such as the pro-inflammatory senescent cells), and to improve functions of "good cells (such as stem cells). Rubedo is developing treatments for aged-related diseases such as Alzhei...
Rubedo Life Sciences is an anti-aging company based in the Silicon Valley, California. Rubedo mission is to extend health-span by targeting cell in the body in an accurate and safe way. We aim to remove from the body "bad cells"​ that drive agin (such as the pro-inflammatory senescent cells), and to improve functions of "good cells (such as stem cells). Rubedo is developing treatments for aged-related diseases such as Alzheimer’s, Cancer, Diabetes, or Arthritis. The company is founded and driven by leaders in aging, regenerative medicine, senescence, combinatorial and medicinal chemistry from top academics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Sunnyvale, California 94085
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251029971777/en/Rubedo-Life-Sciences-and-SVAX-Announce-Strategic-Partnership-During-FII-Week-in-Riyadh

BUSINESSWIRE
30 Oct 2025

https://www.pharmiweb.com/press-release/2025-09-17/rubedo-life-sciences-announces-us-fda-clearance-of-ind-for-selective-gpx4-modulating-lead-drug-can

PHARMAWEB
17 Sep 2025

https://www.businesswire.com/news/home/20250522955270/en/Rubedo-Life-Sciences-Announces-First-Patient-Dosed-with-Lead-Drug-Candidate-RLS-1496-the-First-GPX4-Modulator-Targeting-Pathologic-Senescent-Cells-To-Enter-Phase-1-Clinical-Trial

BUSINESSWIRE
22 May 2025

https://www.businesswire.com/news/home/20250514558243/en/Rubedo-Life-Sciences-Drug-Discovery-Platform-ALEMBIC-Helps-Identify-Senescent-or-Zombie-Neurons-in-New-Study-Linking-Neuropathic-Pain-and-Aging-Published-in-Peer-Reviewed-Scientific-Journal-Nature-Neuroscience

BUSINESSWIRE
14 May 2025

https://www.businesswire.com/news/home/20241111308275/en

BUSINESSWIRE
11 Nov 2024

https://www.businesswire.com/news/home/20241023573741/en

BUSINESSWIRE
23 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty